Open Close
Álvarez-Rendón, J.P., Salceda, R., Riesgo-Escovar, J.R. (2018). Drosophila melanogaster as a Model for Diabetes Type 2 Progression.  Biomed Res. Int. 2018(): 1417528.
FlyBase ID
Publication Type

Drosophila melanogaster has been used as a very versatile and potent model in the past few years for studies in metabolism and metabolic disorders, including diabetes types 1 and 2. Drosophila insulin signaling, despite having seven insulin-like peptides with partially redundant functions, is very similar to the human insulin pathway and has served to study many different aspects of diabetes and the diabetic state. Yet, very few studies have addressed the chronic nature of diabetes, key for understanding the full-blown disease, which most studies normally explore. One of the advantages of having Drosophila mutant viable combinations at different levels of the insulin pathway, with significantly reduced insulin pathway signaling, is that the abnormal metabolic state can be studied from the onset of the life cycle and followed throughout. In this review, we look at the chronic nature of impaired insulin signaling. We also compare these results to the results gleaned from vertebrate model studies.

PubMed ID
PubMed Central ID
PMC5941822 (PMC) (EuropePMC)
Associated Information
Associated Files
Other Information
Secondary IDs
    Language of Publication
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Biomed Res. Int.
    BioMed research international
    2314-6141 2314-6133
    Data From Reference